| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Ligand Pharmaceuticals Inc | |
|---|---|
| Ticker | LGND |
| CIK # | 0000886163 |
| CUSIP | 53220K504 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 11085 North Torrey Pines Road Suite 300, La Jolla, CA 92037 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Ligand Pharmaceuticals Inc | 2016-01-25 | 85.4 M | Exemption: 506(c) · Remaining: $1 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0000886163] | 10-K | |
| [0000886163] | 10-Q | |
| [0000886163] | 3 | |
| [0000886163] | 4 | |
| [0000886163] | 5 | |
| [0000886163] | 8-K | |
| [0000886163] | D | |
| [0000886163] | SC 13D | |
| [0000886163] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sabba Stephen L
Common Stock
|
2026-03-23 | Sell | 1,000 | $207.87 | 207,870 |
|
Espinoza Octavio
Common Stock
|
2026-03-11 | Option exercise | 2,405 | $92.65 | 222,823 |
|
Espinoza Octavio
Employee Stock Option (right to buy) · derivative
|
2026-03-11 | Option exercise | 2,405 | $0.00 | |
|
Espinoza Octavio
Common Stock
|
2026-03-11 | Sell | 3,057 | $225.00 | 687,825 |
|
Lamattina John L
Common Stock
|
2026-03-06 | Option exercise | 2,161 | $114.15 | 246,678 |
|
Lamattina John L
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-06 | Option exercise | 2,161 | $0.00 | |
|
Lamattina John L
Common Stock
|
2026-03-06 | Sell | 2,161 | $200.76 | 433,842 |
|
Espinoza Octavio
Common Stock
|
2026-03-04 | Sell | 668 | $203.63 | 136,025 |
|
Reardon Andrew
Common Stock
|
2026-03-04 | Sell | 93 | $200.62 | 18,658 |
|
Reardon Andrew
Common Stock
|
2026-03-04 | Sell | 100 | $197.70 | 19,770 |
|
Espinoza Octavio
Common Stock
|
2026-03-04 | Sell | 698 | $201.09 | 140,361 |
|
Espinoza Octavio
Common Stock
|
2026-03-04 | Sell | 743 | $204.74 | 152,122 |
|
Reardon Andrew
Common Stock
|
2026-03-04 | Sell | 1,142 | $208.87 | 238,530 |
|
Espinoza Octavio
Common Stock
|
2026-03-04 | Sell | 1,457 | $205.79 | 299,836 |
|
Reardon Andrew
Common Stock
|
2026-03-04 | Sell | 300 | $201.70 | 60,510 |
|
Reardon Andrew
Employee Stock Option (right to buy) · derivative
|
2026-03-04 | Option exercise | 5,000 | $0.00 | |
|
Espinoza Octavio
Common Stock
|
2026-03-04 | Sell | 3,413 | $208.80 | 712,634 |
|
Espinoza Octavio
Common Stock
|
2026-03-04 | Sell | 699 | $198.71 | 138,898 |
|
Espinoza Octavio
Common Stock
|
2026-03-04 | Sell | 697 | $202.79 | 141,345 |
|
Espinoza Octavio
Employee Stock Option (right to buy) · derivative
|
2026-03-04 | Option exercise | 466 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 358 | 20,583,567 |
| 2025-12-31 | 350 | 20,428,343 |
| 2025-09-30 | 314 | 20,509,539 |
| 2025-06-30 | 270 | 19,141,267 |
| 2025-03-31 | 263 | 18,328,011 |
| 2024-12-31 | 261 | 17,817,232 |
| 2024-09-30 | 245 | 17,851,559 |
| 2024-06-30 | 234 | 17,028,544 |
| 2024-03-31 | 223 | 16,960,827 |
| 2023-12-31 | 213 | 16,307,530 |
| 2023-09-30 | 196 | 15,657,687 |
| 2023-06-30 | 204 | 15,483,172 |